RADIOLABELED COMPOUNDS

Martin Edelmann (Inventor)

Research output: Patent

Abstract

The present invention relates to radiolabeled organic compounds. More particularly, the present invention relates to radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful for medical imaging, such as positron-emission tomography (PET), single-photon emission computed tomography (SPECT) and/or autoradiography.
Original languageEnglish
Patent numberWO2021/048241 A1
IPCC07D 498/04,C07B 59/00,A61P 25/16,A61P 25/28,A61P 35/00,A61K 31/5365
Priority date12/09/19
Filing date10/09/20
Publication statusPublished - 18 Mar 2021

Keywords

  • Positron-Emission Tomography
  • MAGL
  • Radionuclides

Cite this